Hillsdale Investment Management Inc. - DICERNA PHARMACEUTICALS INC ownership

DICERNA PHARMACEUTICALS INC's ticker is DRNA and the CUSIP is 253031108. A total of 104 filers reported holding DICERNA PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.6%.

Quarter-by-quarter ownership
Hillsdale Investment Management Inc. ownership history of DICERNA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2020$720,000
-24.8%
40,000
+6.1%
0.07%
-18.4%
Q2 2020$958,000
+31.4%
37,700
-5.0%
0.09%
-1.1%
Q1 2020$729,000
-14.5%
39,700
+2.6%
0.09%
+18.9%
Q4 2019$853,000
+582.4%
38,700
+230.8%
0.07%
+393.3%
Q4 2018$125,00011,7000.02%
Other shareholders
DICERNA PHARMACEUTICALS INC shareholders Q4 2018
NameSharesValueWeighting ↓
Bain Capital Life Sciences Investors, LLC 4,080,237$89,888,00013.40%
EcoR1 Capital, LLC 3,627,597$79,916,0007.20%
Aquilo Capital Management, LLC 614,436$13,536,0005.08%
RTW INVESTMENTS, LP 5,874,229$129,409,0004.88%
BRIDGER MANAGEMENT, LLC 1,981,633$43,655,0003.15%
ACUTA CAPITAL PARTNERS, LLC 387,500$8,537,0002.11%
Integral Health Asset Management, LLC 200,000$4,406,0001.72%
Burrage Capital Management LLC 104,047$2,292,0001.54%
Parkman Healthcare Partners LLC 240,000$5,287,0001.53%
EAM Global Investors LLC 122,237$2,693,0001.08%
View complete list of DICERNA PHARMACEUTICALS INC shareholders